Clinical trial
CAPTURE 2 Post-Marketing Registry
NCT00302237 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00302237 |
|---|---|
| Title | CAPTURE 2 Post-Marketing Registry |
| Official title | Second Phase of "Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events" |
| Acronym | CAPTURE 2 |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Carotid Artery Disease |
| Intervention type | Device |
| Interventions | RX ACCULINK, RX ACCUNET Embolic Protection System |
| Enrollment | 6,426 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 14, 2006 |
| Last update posted | Dec 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: